These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 9206996)

  • 1. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.
    Shuford WW; Klussman K; Tritchler DD; Loo DT; Chalupny J; Siadak AW; Brown TJ; Emswiler J; Raecho H; Larsen CP; Pearson TC; Ledbetter JA; Aruffo A; Mittler RS
    J Exp Med; 1997 Jul; 186(1):47-55. PubMed ID: 9206996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
    Wen T; Bukczynski J; Watts TH
    J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
    J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.
    Vinay DS; Kwon BS
    Cell Immunol; 1999 Feb; 192(1):63-71. PubMed ID: 10066348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner.
    Miller RE; Jones J; Le T; Whitmore J; Boiani N; Gliniak B; Lynch DH
    J Immunol; 2002 Aug; 169(4):1792-800. PubMed ID: 12165501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-linking of 4-1BB activates TCR-signaling pathways in CD8+ T lymphocytes.
    Nam KO; Kang H; Shin SM; Cho KH; Kwon B; Kwon BS; Kim SJ; Lee HW
    J Immunol; 2005 Feb; 174(4):1898-905. PubMed ID: 15699116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.
    Saoulli K; Lee SY; Cannons JL; Yeh WC; Santana A; Goldstein MD; Bangia N; DeBenedette MA; Mak TW; Choi Y; Watts TH
    J Exp Med; 1998 Jun; 187(11):1849-62. PubMed ID: 9607925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation between 4-1BB and ICOS in the immune response to influenza virus revealed by studies of CD28/ICOS-deficient mice.
    Vidric M; Suh WK; Dianzani U; Mak TW; Watts TH
    J Immunol; 2005 Dec; 175(11):7288-96. PubMed ID: 16301634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response.
    Cannons JL; Choi Y; Watts TH
    J Immunol; 2000 Dec; 165(11):6193-204. PubMed ID: 11086053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway.
    Diehl L; van Mierlo GJ; den Boer AT; van der Voort E; Fransen M; van Bostelen L; Krimpenfort P; Melief CJ; Mittler R; Toes RE; Offringa R
    J Immunol; 2002 Apr; 168(8):3755-62. PubMed ID: 11937526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional dichotomy between OX40 and 4-1BB in modulating effector CD8 T cell responses.
    Lee SW; Park Y; Song A; Cheroutre H; Kwon BS; Croft M
    J Immunol; 2006 Oct; 177(7):4464-72. PubMed ID: 16982882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death.
    Hurtado JC; Kim YJ; Kwon BS
    J Immunol; 1997 Mar; 158(6):2600-9. PubMed ID: 9058792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.
    Munks MW; Mourich DV; Mittler RS; Weinberg AD; Hill AB
    Immunology; 2004 Aug; 112(4):559-66. PubMed ID: 15270726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of cord blood CD8+ T-cell effector differentiation by TGF-beta1 and 4-1BB costimulation.
    Kim YJ; Stringfield TM; Chen Y; Broxmeyer HE
    Blood; 2005 Jan; 105(1):274-81. PubMed ID: 15353478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.
    Bertram EM; Dawicki W; Sedgmen B; Bramson JL; Lynch DH; Watts TH
    J Immunol; 2004 Jan; 172(2):981-8. PubMed ID: 14707071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells.
    May KF; Chen L; Zheng P; Liu Y
    Cancer Res; 2002 Jun; 62(12):3459-65. PubMed ID: 12067989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-1BB and OX40 dual costimulation synergistically stimulate primary specific CD8 T cells for robust effector function.
    Lee SJ; Myers L; Muralimohan G; Dai J; Qiao Y; Li Z; Mittler RS; Vella AT
    J Immunol; 2004 Sep; 173(5):3002-12. PubMed ID: 15322159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB.
    Cannons JL; Hoeflich KP; Woodgett JR; Watts TH
    J Immunol; 1999 Sep; 163(6):2990-8. PubMed ID: 10477561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD137 antibodies in the treatment of autoimmune disease and cancer.
    Mittler RS; Foell J; McCausland M; Strahotin S; Niu L; Bapat A; Hewes LB
    Immunol Res; 2004; 29(1-3):197-208. PubMed ID: 15181282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.